Bio Green Med Solution, Inc. Cash Flow Statement
BGMS|8 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 8 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$5M
FY2025
Free Cash Flow
N/A
FY2025
Capital Expenditures
N/A
Cash used for long-term assets
Dividends Paid
N/A
FY2025
Bio Green Med Solution, Inc. used $5M in operating cash flow in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -47.65 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
- Negative return on equity: -43.8% ROE
- Accrual-heavy earnings: Net income significantly exceeds operating cash flow
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.0M | -$7.5M | -$11.8M | -$14.3M | -$19.4M | -$10.2M | -$13.2M | -$15.2M |
| Depreciation & Amortization | - | $32.0M | $100.0K | $200.0K | $200.0K | $200.0K | $60.0K | $241.0K |
| Operating Cash Flow | -$4.8M | -$7.5M | -$10.1M | -$14.5M | -$18.7M | -$18.2M | -$12.0M | -$14.0M |
| Capital Expenditures | - | $13.0K | $3.0K | $34.0K | $309.0K | $208.0K | $12.0K | $6.0K |
| Free Cash Flow | - | -$7.5M | -$10.1M | -$14.5M | -$19.0M | -$18.4M | -$12.1M | -$14.0M |
| Share Buybacks | - | - | - | - | - | $2.0M | $2.0M | $2.0M |
| FCF Margin | - | - | -1196.0% | -745.6% | -1096.4% | -1698.1% | -17471.0% | -143.1% |